Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disorder characterized by hemolysis, cytopenias, bone marrow dysfunction, and thrombosis. Over the last 20 years, we have seen a dramatic unraveling of the pathophysiology of this rare and complex disorder. As a result, new therapies involving complement inhibition have been developed, changing our understanding of the disease and improving outcomes for affected patients.
CITATION STYLE
Weitz, I. C. (2014). Paroxysmal nocturnal hemoglobinuria: New concepts in pathophysiology and treatment. Orphan Drugs: Research and Reviews, 5, 75–81. https://doi.org/10.2147/ODRR.S73641
Mendeley helps you to discover research relevant for your work.